Literature DB >> 14960341

Neuropeptide FF, but not prolactin-releasing peptide, mRNA is differentially regulated in the hypothalamic and medullary neurons after salt loading.

M-L Kalliomäki1, P Panula.   

Abstract

Hypothalamic paraventricular and supraoptic nuclei are involved in the body fluid homeostasis. Especially vasopressin peptide and mRNA levels are regulated by hypo- and hyperosmolar stimuli. Other neuropeptides such as dynorphin, galanin and neuropeptide FF are coregulated with vasopressin. In this study neuropeptide FF and another RF-amide peptide, the prolactin-releasing peptide mRNA levels were studied by quantitative in situ hybridization after chronic salt loading, a laboratory model of chronic dehydration. The neuropeptide FF mRNA expressing cells virtually disappeared from the hypothalamic supraoptic and paraventricular nuclei after salt loading, suggesting that hyperosmolar stress downregulated the NPFF gene transcription. The neuropeptide FF mRNA signal levels were returned to control levels after the rehydration period of 7 days. No changes were observed in those medullary nuclei that express neuropeptide FF mRNA. No significant changes were observed in the hypothalamic or medullary prolactin-releasing peptide mRNA levels. Neuropeptide FF mRNA is drastically downregulated in the hypothalamic magnocellular neurons after salt loading. Other neuropeptides studied in this model are concomitantly coregulated with vasopressin: i.e. their peptide levels are downregulated and mRNA levels are upregulated which is in contrast to neuropeptide FF regulation. It can thus be concluded that neuropeptide FF is not regulated through the vasopressin regulatory system but via an independent pathway. The detailed mechanisms underlying the downregulation of neuropeptide FF mRNA in neurons remain to be clarified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960341     DOI: 10.1016/j.neuroscience.2003.10.026

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Selective mode of action of guanidine-containing non-peptides at human NPFF receptors.

Authors:  Maria Findeisen; Cäcilia Würker; Daniel Rathmann; René Meier; Jens Meiler; Roger Olsson; Annette G Beck-Sickinger
Journal:  J Med Chem       Date:  2012-06-26       Impact factor: 7.446

2.  Microarray analysis of gene expression in the supraoptic nucleus of normoosmotic and hypoosmotic rats.

Authors:  Chunmei Yue; Noriko Mutsuga; Joseph Verbalis; Harold Gainer
Journal:  Cell Mol Neurobiol       Date:  2006-05-13       Impact factor: 5.046

3.  Neuropeptide FF-related gene in fish (Larimichthys polyactis): identification, characterization, and potential anti-inflammatory function.

Authors:  Ran Xiao; Zuting Guo; Li-Bing Zheng; Wei Huang; Chang-Feng Chi; Bao Lou
Journal:  Mol Biol Rep       Date:  2022-05-03       Impact factor: 2.742

4.  Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation.

Authors:  Piotr Wojciechowski; Kryspin Andrzejewski; Katarzyna Kaczyńska
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

5.  Central NPFF signalling is critical in the regulation of glucose homeostasis.

Authors:  Lei Zhang; Julia Koller; Gopana Gopalasingam; Yue Qi; Herbert Herzog
Journal:  Mol Metab       Date:  2022-06-09       Impact factor: 8.568

6.  The hypothalamic neuropeptide FF network is impaired in hypertensive patients.

Authors:  Valeri D Goncharuk; Ruud M Buijs; Jack H Jhamandas; Dick F Swaab
Journal:  Brain Behav       Date:  2014-04-10       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.